Cargando…
P863: AN OPEN-LABEL PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCS1477 AS MONOTHERAPY AND IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431102/ http://dx.doi.org/10.1097/01.HS9.0000970356.54143.bc |
| _version_ | 1785091120229777408 |
|---|---|
| author | Searle, Emma Cavet, Jim Knapper, Steven Bygrave, Ceri Campbell, Victoria El-Sharkawi, Dima Pawlyn, Charlotte Creignou, Maria Walter, Harriet S. Valcarcel, David Hidalgo, Marta Knurowski, Tomasz Clegg, Karen Pegg, Neil West, Will Haynes, Debbie Frese, Kris Somervaille, Tim C. P. |
| author_facet | Searle, Emma Cavet, Jim Knapper, Steven Bygrave, Ceri Campbell, Victoria El-Sharkawi, Dima Pawlyn, Charlotte Creignou, Maria Walter, Harriet S. Valcarcel, David Hidalgo, Marta Knurowski, Tomasz Clegg, Karen Pegg, Neil West, Will Haynes, Debbie Frese, Kris Somervaille, Tim C. P. |
| author_sort | Searle, Emma |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431102 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104311022023-08-17 P863: AN OPEN-LABEL PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCS1477 AS MONOTHERAPY AND IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA Searle, Emma Cavet, Jim Knapper, Steven Bygrave, Ceri Campbell, Victoria El-Sharkawi, Dima Pawlyn, Charlotte Creignou, Maria Walter, Harriet S. Valcarcel, David Hidalgo, Marta Knurowski, Tomasz Clegg, Karen Pegg, Neil West, Will Haynes, Debbie Frese, Kris Somervaille, Tim C. P. Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431102/ http://dx.doi.org/10.1097/01.HS9.0000970356.54143.bc Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Searle, Emma Cavet, Jim Knapper, Steven Bygrave, Ceri Campbell, Victoria El-Sharkawi, Dima Pawlyn, Charlotte Creignou, Maria Walter, Harriet S. Valcarcel, David Hidalgo, Marta Knurowski, Tomasz Clegg, Karen Pegg, Neil West, Will Haynes, Debbie Frese, Kris Somervaille, Tim C. P. P863: AN OPEN-LABEL PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCS1477 AS MONOTHERAPY AND IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title | P863: AN OPEN-LABEL PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCS1477 AS MONOTHERAPY AND IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full | P863: AN OPEN-LABEL PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCS1477 AS MONOTHERAPY AND IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_fullStr | P863: AN OPEN-LABEL PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCS1477 AS MONOTHERAPY AND IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full_unstemmed | P863: AN OPEN-LABEL PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCS1477 AS MONOTHERAPY AND IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_short | P863: AN OPEN-LABEL PHASE I/IIA STUDY TO EVALUATE THE SAFETY AND EFFICACY OF CCS1477 AS MONOTHERAPY AND IN COMBINATION WITH POMALIDOMIDE/DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_sort | p863: an open-label phase i/iia study to evaluate the safety and efficacy of ccs1477 as monotherapy and in combination with pomalidomide/dexamethasone in relapsed/refractory multiple myeloma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431102/ http://dx.doi.org/10.1097/01.HS9.0000970356.54143.bc |
| work_keys_str_mv | AT searleemma p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT cavetjim p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT knappersteven p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT bygraveceri p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT campbellvictoria p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT elsharkawidima p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT pawlyncharlotte p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT creignoumaria p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT walterharriets p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT valcarceldavid p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT hidalgomarta p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT knurowskitomasz p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT cleggkaren p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT peggneil p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT westwill p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT haynesdebbie p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT fresekris p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma AT somervailletimcp p863anopenlabelphaseiiiastudytoevaluatethesafetyandefficacyofccs1477asmonotherapyandincombinationwithpomalidomidedexamethasoneinrelapsedrefractorymultiplemyeloma |